Sartorius | SRT3 - Ebit

Aktienkurs
217.10
Täglich Wechseln
2.20 1.02%
Monatlich
0.74%
Jährlich
-3.12%
Q2 Prognose
211.39




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.39M 1.72M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 28M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 160.7M 94.1M 2026-03
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12